Fate Therapeutics
FATE
#8676
Rank
ยฃ0.12 B
Marketcap
ยฃ1.10
Share price
-5.13%
Change (1 day)
26.80%
Change (1 year)

Fate Therapeutics (FATE) Fails to deliver data

Key failure to deliver metrics for Fate Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Fate Therapeutics (FATE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013

Volume in USD (price x number of shares), data since 2013

Fate Therapeutics (FATE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ1.38 M14.86%
2024ยฃ1.2 M-44.15%
2023ยฃ2.15 M-89.19%
2022ยฃ19.92 M-20.28%
2021ยฃ24.99 M31.2%
2020ยฃ19.05 M9.95%
2019ยฃ17.32 M59.52%
2018ยฃ10.86 M1415.4%
2017ยฃ0.71 M181.93%
2016ยฃ0.25 M-79.05%
2015ยฃ1.21 M-17.49%
2014ยฃ1.47 M-81.78%
2013ยฃ8.07 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Becton Dickinson
BDX
ยฃ23.52 Mยฃ94.42 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ3.87 Mยฃ21.35 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
ยฃ9.81 Mยฃ41.89 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ5.02 Mยฃ29.2 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
ยฃ14.4 Mยฃ46.49 M๐Ÿ‡บ๐Ÿ‡ธ USA